NCT04374773View on ClinicalTrials.gov

Effects of Pregnancy-associated Hormones on THC Metabolism in Women

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

August 14, 2025

Study Completion Date

December 31, 2025

Conditions
Pregnancy RelatedCannabis Use
Interventions
DRUG

Dronabinol

2.5 mg PO administered once prior to and once after 1 week of hormone therapy

Trial Locations (1)

98125

Nina Isoherranen, Seattle

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Washington

OTHER